Latest Content

FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers

June 27th 2025, 4:00pm

By Ryan Scott

Article

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and multiple myeloma, respectively.

CAR T Transforms Treatment Landscape for Blood Cancers

June 27th 2025, 3:00pm

By Spencer Feldman

Article

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, says Dr. André Goy.

Side Effects of BGB-16673 Appear Manageable in Early CLL Study

June 27th 2025, 1:00pm

By Dr. Lydia Scarfò

Video

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.

It’s Me, A Cancer Survivor, I Refuse to Be Ignored

June 26th 2025, 9:00pm

By Brian Sluga

Article

I was diagnosed with testicular cancer at 20. I’ve learned to embrace the pauses in life and stand proud as a survivor who won’t be ignored.

A Cancer Thriver Breaks Down Her Definition of Survivorship

June 26th 2025, 8:00pm

By Valarie Traynham

Video

Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.

June Blood Cancer Highlights: Top 5 Updates Patients Should Know

June 26th 2025, 7:00pm

By Ryan Scott

Article

June brought major blood cancer updates, and CURE is sharing the latest in myelofibrosis treatment and FDA breakthroughs, as well as survivorship news.

Making Prostate Cancer Easier to Understand for Newly Diagnosed Patients

June 26th 2025, 5:00pm

By Ryan Scott

Article

Dr. Ravi Munver explained that, for patients who are recently diagnosed with prostate cancer, it is important to explore treatment option with their care.

Caring for Patients With Cancer Beyond Remission

June 26th 2025, 4:00pm

By Sue McCarthy

Article

I entered remission from lung cancer 5.5 years ago, but faced a tough road readjusting, with ongoing physical, mental and emotional challenges.

FDA Grants Priority Review to Revuforj for Mutant NPM1 AML

June 26th 2025, 3:00pm

By Spencer Feldman

Article

The FDA has granted priority review to an application for Revuforj for the treatment of relapsed or refractory mutant NPM1 acute myeloid leukemia.

Eating Tips for When Cancer Treatment Makes Meals Challenging

June 26th 2025, 1:00pm

By Spencer Feldman

Article

Greek yogurt, egg salad, avocado and mac and cheese are easy-to-swallow, high-calorie foods that can help patients maintain strength during cancer treatment.

When Cancer Advocacy Becomes a Lifeline

June 25th 2025, 9:00pm

By Morgan Newman

Article

Cancer survivor Morgan Newman shares how self-advocacy helped her overcome barriers to care and find the support she needed after treatment.

CAR T-Cell Therapy Leads to Remission in Retired Air Force Pilot With Lymphoma

June 25th 2025, 8:00pm

By Dr. Andre Henri Goy

Video

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

June 25th 2025, 7:00pm

By Ryan Scott

Article

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.

Traveling with Multiple Myeloma: A Journey of Adaptation and Hope

June 25th 2025, 5:00pm

By Ronald Chin

Article

I share how traveling fueled my passion for life, how myeloma changed my journeys, and how new mobility options have opened doors to adventure and connection.

What Patients With GIST Should Know About Their Disease

June 25th 2025, 4:00pm

By Ryan Scott

Article

Dr. Breelyn Wilky discusses some of the most recent advancements in GIST treatment, as well as touched on the role of personalized therapy.